Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
851
Metallus
MTUS
$829M
| $14.9M | 0.02% |
968,533
-4,600
| -0.5% | -$61.3K |
2020 Q1
21 quarters
|
|
852
First Busey Corp
BUSE
$2.39B
| $14.9M | 0.02% |
652,046
-113,800
| -15% | -$2.46M |
2013 Q2
48 quarters
|
|
853
Preformed Line Products
PLPC
$1.94B
| $14.9M | 0.02% |
93,116
+29,900
| +47% | +$4.26M |
2015 Q2
40 quarters
|
|
854
LifeMD
LFMD
$127M
| $14.8M | 0.02% |
1,086,200
+600,100
| +123% | +$5.67M |
2022 Q4
10 quarters
|
|
855
Zoetis
ZTS
$30.9B
| $14.8M | 0.02% |
+94,600
| New | +$15M |
2025 Q2
0 quarters
|
|
856
RenaissanceRe
RNR
$13.8B
| $14.7M | 0.02% |
+60,682
| New | +$14.7M |
2025 Q2
0 quarters
|
|
857
Ardmore Shipping
ASC
$788M
| $14.7M | 0.02% |
1,530,528
+169,371
| +12% | +$1.63M |
2021 Q4
14 quarters
|
|
858
Central Garden & Pet Co Class A
CENTA
$2.19B
| $14.7M | 0.02% |
468,575
+23,700
| +5% | +$740K |
2013 Q2
48 quarters
|
|
859
Haverty Furniture Companies
HVT
$425M
| $14.6M | 0.02% |
717,606
+4,000
| +0.6% | +$78.1K |
2013 Q2
48 quarters
|
|
860
AptarGroup
ATR
$7.65B
| $14.6M | 0.02% |
93,100
-30,900
| -25% | -$4.67M |
2022 Q1
13 quarters
|
|
|
OLP
861
One Liberty Properties
OLP
$481M
| $14.6M | 0.02% |
610,051
-11,700
| -2% | -$286K |
2013 Q2
48 quarters
|
|
862
Nomura Holdings
NMR
$28B
| $14.6M | 0.02% |
2,211,337
+240,400
| +12% | +$1.41M |
2019 Q1
25 quarters
|
|
863
Pfizer
PFE
$161B
| $14.5M | 0.02% |
600,033
-151,991
| -20% | -$3.54M |
2025 Q1
1 quarter
|
|
864
National Fuel Gas
NFG
$7.48B
| $14.5M | 0.02% |
+171,621
| New | +$13.9M |
2025 Q2
0 quarters
|
|
|
NFBK
865
DELISTED
Northfield Bancorp
NFBK
| $14.5M | 0.02% |
1,266,049
+61,900
| +5% | +$687K |
2013 Q2
48 quarters
|
|
866
Axsome Therapeutics
AXSM
$8.82B
| $14.5M | 0.02% |
138,700
+4,300
| +3% | +$455K |
2025 Q1
1 quarter
|
|
867
CEMIG Preferred Shares
CIG
$6.87B
| $14.4M | 0.02% |
7,346,349
+452,000
| +7% | +$827K |
2018 Q4
26 quarters
|
|
868
Chefs' Warehouse
CHEF
$4.66B
| $14.4M | 0.02% |
225,171
+140,249
| +165% | +$8.33M |
2024 Q2
4 quarters
|
|
869
Hilton Worldwide
HLT
$73.5B
| $14.3M | 0.02% |
53,800
-297,700
| -85% | -$70.9M |
2022 Q2
12 quarters
|
|
870
Nu Skin
NUS
$231M
| $14.3M | 0.02% |
1,790,199
-43,497
| -2% | -$305K |
2017 Q4
30 quarters
|
|
871
First Trust Smith Unconstrained Bond ETF
UCON
$3.2B
| $14.3M | 0.02% |
573,233
+62,833
| +12% | +$1.55M |
2023 Q4
6 quarters
|
|
872
Valaris
VAL
$5.81B
| $14.2M | 0.02% |
+338,000
| New | +$12.7M |
2025 Q2
0 quarters
|
|
873
Vishay Precision Group
VPG
$967M
| $14.2M | 0.02% |
504,673
-22,300
| -4% | -$549K |
2013 Q2
48 quarters
|
|
874
Tetra Tech
TTEK
$8.54B
| $14.1M | 0.02% |
392,500
+127,500
| +48% | +$4.24M |
2023 Q3
7 quarters
|
|
|
EXK
875
Endeavour Silver
EXK
$2.56B
| $14.1M | 0.02% |
2,864,997
+2,495,797
| +676% | +$9.83M |
2024 Q3
3 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.